FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to veterinary science, and concerns treating corneal diseases in dogs. For this purpose, mesenchymal cord and placental stem cells received after easy human delivery are used. The mesenchymal stem cells are introduced retrobulbarly in saline solution 1-2 ml containing 0.075-0.20×106 cell/kg. The cells are introduced 1-2 times annually.
EFFECT: method provides the effective treatment of corneal diseases in dogs by creating the depot stem cells in a close proximity to the lesion.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PARALYSIS AND EPILEPSY TREATMENT IN DOGS | 2008 |
|
RU2371187C1 |
THERAPY OF ARTHROSIS | 2007 |
|
RU2360691C1 |
METHOD OF DOG ORGANISM BIOSTIMULATION | 2008 |
|
RU2371188C1 |
METHOD OF TREATING TEMPOROMANDIBULAR JOINT ARTHROSIS | 2010 |
|
RU2440062C1 |
METHOD OF TREATING PERIODONTITIS | 2010 |
|
RU2440060C1 |
METHOD FOR TREATMENT OF BRAIN CONFUSION | 2007 |
|
RU2347578C1 |
METHOD FOR DEVELOPING A DEPOT OF MEDICINAL SUBSTANCES IN THE FIELD OF OPHTHALMOLOGY | 2004 |
|
RU2268689C1 |
METHOD OF TREATMENT OF ISCHEMIC ANGIOPATHY OF LOWER EXTREMITY VESSELS | 2017 |
|
RU2649498C1 |
METHOD FOR OBTAINING OF BIOSAFE CULTURE OF MESENCHIMAL STEM CELLS FROM HUMAN CHORIONIC VILLAE | 2016 |
|
RU2645255C1 |
METHOD FOR OBTAINING BIOSAFE CULTURE OF MESENCHYMAL STEM CELLS FROM GELATIN OF WHARTON OF HUMAN UMBILICAL CORD | 2016 |
|
RU2674344C2 |
Authors
Dates
2013-05-10—Published
2011-11-17—Filed